[go: up one dir, main page]

ATE380542T1 - Topische zusammensetzung enthaltend mindestens ein vitamin d oder vitamin d analogon und mindestens ein corticosteroid - Google Patents

Topische zusammensetzung enthaltend mindestens ein vitamin d oder vitamin d analogon und mindestens ein corticosteroid

Info

Publication number
ATE380542T1
ATE380542T1 AT01971719T AT01971719T ATE380542T1 AT E380542 T1 ATE380542 T1 AT E380542T1 AT 01971719 T AT01971719 T AT 01971719T AT 01971719 T AT01971719 T AT 01971719T AT E380542 T1 ATE380542 T1 AT E380542T1
Authority
AT
Austria
Prior art keywords
vitamin
corticosteroid
analogue
composition containing
topical composition
Prior art date
Application number
AT01971719T
Other languages
English (en)
Inventor
Gert Hoy
Erik Didriksen
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE380542(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharma As filed Critical Leo Pharma As
Application granted granted Critical
Publication of ATE380542T1 publication Critical patent/ATE380542T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01971719T 2000-10-27 2001-09-26 Topische zusammensetzung enthaltend mindestens ein vitamin d oder vitamin d analogon und mindestens ein corticosteroid ATE380542T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24347100P 2000-10-27 2000-10-27

Publications (1)

Publication Number Publication Date
ATE380542T1 true ATE380542T1 (de) 2007-12-15

Family

ID=22918889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01971719T ATE380542T1 (de) 2000-10-27 2001-09-26 Topische zusammensetzung enthaltend mindestens ein vitamin d oder vitamin d analogon und mindestens ein corticosteroid

Country Status (21)

Country Link
US (1) US6787529B2 (de)
EP (1) EP1331927B1 (de)
JP (3) JP4451061B2 (de)
KR (1) KR100844285B1 (de)
CN (1) CN100382803C (de)
AT (1) ATE380542T1 (de)
AU (2) AU2001291637B2 (de)
BR (1) BRPI0114927B8 (de)
CA (1) CA2423930C (de)
CY (1) CY1107294T1 (de)
CZ (1) CZ305984B6 (de)
DE (1) DE60131881T2 (de)
DK (1) DK1331927T3 (de)
ES (1) ES2298264T3 (de)
HU (1) HU230005B1 (de)
IL (2) IL154888A0 (de)
MX (1) MXPA03003511A (de)
PL (1) PL212660B1 (de)
PT (1) PT1331927E (de)
RU (1) RU2271810C2 (de)
WO (1) WO2002034235A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
PL212660B1 (pl) * 2000-10-27 2012-11-30 Leo Pharma As Zasadniczo niewodna zelowa kompozycja farmaceutyczna do podawania na skóre oraz jej zastosowanie
US20090143328A1 (en) * 2001-08-13 2009-06-04 Mcdonald George Method of Treating Cancer by Administration of Topical Active Corticosteroids
MXPA05003805A (es) * 2002-12-17 2005-06-08 Galderma Sa Composiciones farmaceuticas que comprenden una combinacion de calcitriol y propionato de clobetasol.
FR2854802B1 (fr) * 2003-05-12 2005-06-24 Galderma Res & Dev Procede de preparation d'une formulation contenant un principe actif microdose
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871693B1 (fr) * 2004-06-17 2006-08-25 Galderma Sa Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
CA2581693A1 (en) * 2004-07-28 2006-02-02 Lipopeptide Ab New use
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
CN101193641B (zh) 2005-05-10 2013-05-29 德米普瑟尔有限公司 用于治疗表皮过度增殖疾病的组合物和方法
NZ563560A (en) * 2005-06-01 2009-11-27 Stiefel Res Australia Pty Ltd Vitamin formulation for treating a dermatological skin disorder
RU2008100037A (ru) * 2005-06-10 2009-07-20 Галдерма С.А. (Ch) Способ регулируемого высвобождения лекарственного средства через кожу
MXPA05009381A (es) * 2005-09-02 2007-03-01 Fernando Ahumada Ayala Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
RU2412165C2 (ru) 2006-03-17 2011-02-20 Лео Фарма А/С Изомеризация фармацевтических интермедиатов
CN101505725A (zh) * 2006-08-29 2009-08-12 特瓦制药工业有限公司 包含含维生素D的化合物和皮质类固醇化合物的具有低pH相容性的稳定的药理学活性组合物
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
ES2272198B1 (es) * 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
EP1970048A1 (de) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topische Zusammensetzung mit Vitamin D
EP1970049A1 (de) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topische Zusammensetzung mit Vitamin D und Kortikosteroid
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
EP3354276B1 (de) 2007-11-13 2020-01-01 Meritage Pharma, Inc. Zusammensetzungen zur behandlung von magen-darm-entzündung
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
AU2010335654B2 (en) * 2009-12-22 2015-04-09 Leo Pharma A/S Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants
US9254296B2 (en) * 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
PL2515874T3 (pl) * 2009-12-22 2015-01-30 Leo Pharma As Nanokryształy jednowodnego kalcypotriolu
HRP20150154T1 (hr) 2010-06-11 2015-04-10 Leo Pharma A/S Raspršivi farmaceutski pripravak koji sadrži analog vitamina d i kortikosteroid
RU2429818C1 (ru) * 2010-06-28 2011-09-27 Государственное учреждение здравоохранения "Кемеровская областная клиническая больница" Лечебное средство
RU2442565C1 (ru) * 2010-08-27 2012-02-20 Государственное учреждение здравоохранения "Кемеровская областная клиническая больница" Лечебная мазь
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) * 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
AU2012228273B2 (en) 2011-03-14 2015-08-20 Drug Delivery Solutions Limited An ophthalmic composition
JP5897299B2 (ja) * 2011-10-14 2016-03-30 岩城製薬株式会社 ローション剤
CN104138352B (zh) * 2013-04-19 2018-02-27 江苏知原药业有限公司 卡泊三醇非水凝胶
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
KR102779108B1 (ko) * 2015-06-18 2025-03-07 밸리언트 파마슈티컬즈 노오쓰 아메리카 엘엘씨 건선을 치료하기 위한 코르티코스테로이드 및 레티노이드를 포함하는 국소 조성물
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
KR102354028B1 (ko) 2020-05-13 2022-01-24 동국대학교 경주캠퍼스 산학협력단 건선 예방, 개선 또는 치료용 피부 외용제 조성물
CN114159567B (zh) * 2020-09-10 2023-03-31 南京海融医药科技股份有限公司 一种治疗皮肤病的混悬凝胶剂
CN115569199B (zh) * 2022-02-14 2024-08-20 海勃(上海)医药科技有限公司 一种药物组合物及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
SE457055B (sv) * 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
ATE104554T1 (de) * 1990-01-10 1994-05-15 Hoffmann La Roche Topische praeparate.
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
US5763428A (en) * 1990-09-21 1998-06-09 Bone Care International, Inc. Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
JP2571493B2 (ja) * 1992-06-04 1997-01-16 株式会社資生堂 皮膚外用剤
AU4841193A (en) * 1992-08-28 1994-03-29 Lunar Corporation 1alpha,24(S)-dihydroxy vitamin D2, its formation and use
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
DE4328217C2 (de) * 1993-08-21 1996-01-11 Lohmann Therapie Syst Lts Therapeutisches System zur Behandlung der Psoriasis
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
FR2740042B1 (fr) * 1995-10-23 1997-11-14 Oreal Support, et composition contenant ce support et un actif cosmetique ou dermatologique stabilise
JPH10158147A (ja) * 1996-11-29 1998-06-16 Kenji Nakamura 皮膚保護用の被膜組成物とそれを用いた製品
WO1998047534A1 (de) * 1997-04-18 1998-10-29 Klinge Pharma Gmbh Stabilisiertes arzneimittel enthaltend cysteinylderivate
JPH11188054A (ja) * 1997-12-25 1999-07-13 Lion Corp 皮膚外用部材
US5990100A (en) 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
FR2785284B1 (fr) * 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
HRP20010779B1 (hr) 1999-04-23 2011-02-28 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab) Farmaceutski pripravak
PL212660B1 (pl) * 2000-10-27 2012-11-30 Leo Pharma As Zasadniczo niewodna zelowa kompozycja farmaceutyczna do podawania na skóre oraz jej zastosowanie

Also Published As

Publication number Publication date
AU2001291637B2 (en) 2006-04-06
HK1077208A1 (en) 2006-02-10
PL212660B1 (pl) 2012-11-30
BR0114927B1 (pt) 2017-12-05
EP1331927A1 (de) 2003-08-06
WO2002034235A1 (en) 2002-05-02
US20020111336A1 (en) 2002-08-15
JP4451061B2 (ja) 2010-04-14
CA2423930A1 (en) 2002-05-02
CN1633280A (zh) 2005-06-29
DK1331927T3 (da) 2008-05-05
MXPA03003511A (es) 2004-05-04
BRPI0114927B8 (pt) 2021-05-25
HUP0302881A3 (en) 2012-03-28
AU9163701A (en) 2002-05-06
JP2008297310A (ja) 2008-12-11
HU230005B1 (en) 2015-04-28
PT1331927E (pt) 2008-01-30
JP5699169B2 (ja) 2015-04-08
CN100382803C (zh) 2008-04-23
IL154888A (en) 2013-12-31
CA2423930C (en) 2009-11-24
JP5721927B2 (ja) 2015-05-20
BR0114927A (pt) 2003-12-23
JP2013075924A (ja) 2013-04-25
DE60131881D1 (de) 2008-01-24
EP1331927B1 (de) 2007-12-12
IL154888A0 (en) 2003-10-31
KR100844285B1 (ko) 2008-07-09
KR20030048083A (ko) 2003-06-18
PL360941A1 (en) 2004-09-20
CZ305984B6 (cs) 2016-06-08
RU2271810C2 (ru) 2006-03-20
US6787529B2 (en) 2004-09-07
HUP0302881A2 (hu) 2003-12-29
CY1107294T1 (el) 2012-11-21
DE60131881T2 (de) 2008-12-04
ES2298264T3 (es) 2008-05-16
JP2004512297A (ja) 2004-04-22

Similar Documents

Publication Publication Date Title
ATE380542T1 (de) Topische zusammensetzung enthaltend mindestens ein vitamin d oder vitamin d analogon und mindestens ein corticosteroid
YU75701A (sh) Farmaceutski preparat
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
CY2016031I2 (el) Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
BR0210139A (pt) Composições farmacêuticas
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BR0100046A (pt) Copolìmeros reticulados solúveis em água ou intumescìveis em água
BR0207726A (pt) Sais farmacêuticos
SE0001899D0 (sv) New compounds
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
DE602006009259D1 (de) Pharmazeutische zusammensetzung mit einem organopoirkstoff
BRPI0611526A2 (pt) composição tópica contendo gelatina
FR2824474B1 (fr) Composition cosmetique a base de sucralfate et de sulfates de cuivre et de zinc
WO2003105751A3 (en) NEW CURCUMIN DERIVATIVES
AR030140A1 (es) Composiciones derivadas de la 2-piridinamina y metodos relacionados
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
CR7198A (es) Tableta que contiene cetirizina y pseudoefedrina
DE60309480D1 (de) Vitamin d-analoge
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
BR0309266A (pt) Uso de composições tópicas para o controle de doenças microbianas da unha
BR9714945A (pt) Composição topicamente aplicável para introdução de fármacos peptidaceosos em organismos vivos
ATE241640T1 (de) Fusidinsäure-derivate
IT1265647B1 (it) Composizione farmaceutiche topiche per le allergie respiratorie
ES2187446T3 (es) Composicion para el tratamiento de la psoriasis.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1331927

Country of ref document: EP